Literature DB >> 18848497

Recent insights into humoral and cellular immune responses against malaria.

James G Beeson1, Faith H A Osier, Christian R Engwerda.   

Abstract

Effective immunity to malaria has been clearly demonstrated among individuals naturally exposed to malaria, and can be induced by experimental infections in animals and humans. The large number of malaria antigens has presented a major challenge to identifying protective responses and their targets, and it is likely that robust immunity is mediated by responses to multiple antigens. These include merozoite surface antigens and invasion ligands, variant antigens on the surface of parasitized red blood cells, in addition to sporozoite and liver-stage antigens. Immunity seems to require humoral and cellular immune components, probably in co-operation, although the relative importance of each remains unclear. This review summarizes recent progress towards understanding the targets and mechanisms that are important for mediating immunity to malaria.

Entities:  

Mesh:

Year:  2008        PMID: 18848497     DOI: 10.1016/j.pt.2008.08.008

Source DB:  PubMed          Journal:  Trends Parasitol        ISSN: 1471-4922


  58 in total

1.  Immune characterization of Plasmodium falciparum parasites with a shared genetic signature in a region of decreasing transmission.

Authors:  Amy K Bei; Ababacar Diouf; Kazutoyo Miura; Daniel B Larremore; Ulf Ribacke; Gregory Tullo; Eli L Moss; Daniel E Neafsey; Rachel F Daniels; Amir E Zeituni; Iguosadolo Nosamiefan; Sarah K Volkman; Ambroise D Ahouidi; Daouda Ndiaye; Tandakha Dieye; Souleymane Mboup; Caroline O Buckee; Carole A Long; Dyann F Wirth
Journal:  Infect Immun       Date:  2014-11-03       Impact factor: 3.441

2.  Evaluation of the antigenic diversity of placenta-binding Plasmodium falciparum variants and the antibody repertoire among pregnant women.

Authors:  Mirja Hommel; Salenna R Elliott; Viju Soma; Greg Kelly; Freya J I Fowkes; Joanne M Chesson; Michael F Duffy; Joseph Bockhorst; Marion Avril; Ivo Mueller; Andrew Raiko; Danielle I Stanisic; Stephen J Rogerson; Joseph D Smith; James G Beeson
Journal:  Infect Immun       Date:  2010-02-16       Impact factor: 3.441

3.  Artesunate versus chloroquine infection-treatment-vaccination defines stage-specific immune responses associated with prolonged sterile protection against both pre-erythrocytic and erythrocytic Plasmodium yoelii infection.

Authors:  Xiaohong Peng; Gladys J Keitany; Marissa Vignali; Lin Chen; Claire Gibson; Kimberly Choi; Fusheng Huang; Ruobing Wang
Journal:  J Immunol       Date:  2014-06-23       Impact factor: 5.422

4.  Identification and characterization of the Plasmodium falciparum RhopH2 ortholog in Plasmodium vivax.

Authors:  Bo Wang; Feng Lu; Yang Cheng; Jian Li; Daisuke Ito; Jetsumon Sattabongkot; Takafumi Tsuboi; Eun-Taek Han
Journal:  Parasitol Res       Date:  2012-10-25       Impact factor: 2.289

5.  γδ T Cells Kill Plasmodium falciparum in a Granzyme- and Granulysin-Dependent Mechanism during the Late Blood Stage.

Authors:  Maria Andrea Hernández-Castañeda; Katharina Happ; Filippo Cattalani; Alexandra Wallimann; Marianne Blanchard; Isabelle Fellay; Brigitte Scolari; Nils Lannes; Smart Mbagwu; Benoît Fellay; Luis Filgueira; Pierre-Yves Mantel; Michael Walch
Journal:  J Immunol       Date:  2020-02-17       Impact factor: 5.422

Review 6.  Young lives lost as B cells falter: what we are learning about antibody responses in malaria.

Authors:  Silvia Portugal; Susan K Pierce; Peter D Crompton
Journal:  J Immunol       Date:  2013-04-01       Impact factor: 5.422

7.  Impact of child malnutrition on the specific anti-Plasmodium falciparum antibody response.

Authors:  Florie Fillol; Jean Biram Sarr; Denis Boulanger; Badara Cisse; Cheikh Sokhna; Gilles Riveau; Kirsten Bork Simondon; Franck Remoué
Journal:  Malar J       Date:  2009-06-02       Impact factor: 2.979

8.  Long-lived antibody and B Cell memory responses to the human malaria parasites, Plasmodium falciparum and Plasmodium vivax.

Authors:  Jiraprapa Wipasa; Chaisuree Suphavilai; Lucy C Okell; Jackie Cook; Patrick H Corran; Kanitta Thaikla; Witaya Liewsaree; Eleanor M Riley; Julius Clemence R Hafalla
Journal:  PLoS Pathog       Date:  2010-02-19       Impact factor: 6.823

9.  The synthetic Plasmodium falciparum circumsporozoite peptide PfCS102 as a malaria vaccine candidate: a randomized controlled phase I trial.

Authors:  Régine Audran; Floriana Lurati-Ruiz; Blaise Genton; Hildur E Blythman; Opokua Ofori-Anyinam; Christophe Reymond; Giampietro Corradin; François Spertini
Journal:  PLoS One       Date:  2009-10-02       Impact factor: 3.240

10.  Malarial hemozoin is a Nalp3 inflammasome activating danger signal.

Authors:  Catherine Dostert; Greta Guarda; Jackeline F Romero; Philippe Menu; Olaf Gross; Aubry Tardivel; Mario-Luca Suva; Jean-Christophe Stehle; Manfred Kopf; Ivan Stamenkovic; Giampietro Corradin; Jurg Tschopp
Journal:  PLoS One       Date:  2009-08-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.